{"count": 1, "results": [{"_id": "37185294", "pmid": 37185294, "pmcid": "PMC10198605", "title": "A Targeted, Low-Throughput Compound Screen in a Drosophila Model of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD)", "journal": "eNeuro", "authors": ["Dyson A", "Ryan M", "Garg S", "Evans DG", "Baines RA"], "date": "2023-05-16T00:00:00Z", "doi": "10.1523/ENEURO.0461-22.2023", "meta_date_publication": "2023 May", "meta_volume": "10", "meta_issue": "5", "meta_pages": "", "score": 50257.4, "text_hl": "A Targeted, Low-Throughput Compound Screen in a @SPECIES_7227 @@@Drosophila@@@ Model of @GENE_NF1 @GENE_4763 @@@Neurofibromatosis Type 1@@@ Identifies @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_BMS204352 @CHEMICAL_MESH:C424388 @@@BMS-204352@@@ as Potential Therapies for @<m>DISEASE_Autism_Spectrum_Disorder</m> @DISEASE_MESH:D000067877 @@@Autism Spectrum Disorder@@@ (@<m>DISEASE_Autism_Spectrum_Disorder</m> @DISEASE_MESH:D000067877 @@@ASD@@@)", "citations": {"NLM": "Dyson A, Ryan M, Garg S, Evans DG, Baines RA. A Targeted, Low-Throughput Compound Screen in a Drosophila Model of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD) eNeuro. 2023 May;10(5):. PMID: 37185294", "BibTeX": "@article{37185294, title={A Targeted, Low-Throughput Compound Screen in a Drosophila Model of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD)}, author={Dyson A and Ryan M and Garg S and Evans DG and Baines RA}, journal={eNeuro}, volume={10}, number={5}}"}}]}